A detailed history of Bruce & Co., Inc. transactions in Organon & Co. stock. As of the latest transaction made, Bruce & Co., Inc. holds 31,370 shares of OGN stock, worth $479,333. This represents 0.25% of its overall portfolio holdings.

Number of Shares
31,370
Previous 31,370 -0.0%
Holding current value
$479,333
Previous $649,000 7.55%
% of portfolio
0.25%
Previous 0.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$17.45 - $21.96 $3,141 - $3,952
180 Added 0.58%
31,370 $649,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $4,645 - $6,655
-280 Reduced 0.89%
31,190 $541,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $11,655 - $14,305
-500 Reduced 1.56%
31,470 $879,000
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $12,180 - $15,744
-400 Reduced 1.24%
31,970 $1.12 Million
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $926,753 - $1.15 Million
32,370 New
32,370 $1.06 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bruce & Co., Inc. Portfolio

Follow Bruce & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.